Paloma Partners’s American Renal Associates Holdings, Inc ARA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q3
Sell
-10,900
Closed -$71K 2671
2020
Q2
$71K Buy
+10,900
New +$70.4K ﹤0.01% 1959
2019
Q4
Sell
-13,400
Closed -$85K 2640
2019
Q3
$85K Buy
+13,400
New +$99.9K ﹤0.01% 1850
2018
Q3
Sell
-22,587
Closed -$356K 2083
2018
Q2
$356K Buy
+22,587
New +$355K 0.01% 1191

Other funds holding ARA

Paloma Partners's ARA Position: Q3 2020 in Review

Paloma Partners sold out of American Renal Associates Holdings, Inc (ARA) in Q3 2020, closing a stake of 10,900 shares — an estimated $71K sold.

Paloma Partners first reported a position in ARA in Q2 2018 and held it in 3 quarters. The position peaked at $356K in Q2 2018. 56 funds tracked by Wall St. Rank hold ARA as of Q3 2020.

  • Paloma Partners reported no remaining American Renal Associates Holdings, Inc position as of Q3 2020 after selling out during the quarter.
  • Paloma Partners sold 10,900 American Renal Associates Holdings, Inc shares in Q3 2020, an estimated $71K.
  • Paloma Partners first reported a position in American Renal Associates Holdings, Inc in Q2 2018 and held it in 3 quarters.
  • Paloma Partners's American Renal Associates Holdings, Inc position peaked at $356K in Q2 2018.
  • 56 funds tracked by Wall St. Rank held American Renal Associates Holdings, Inc as of Q3 2020.

Based on Paloma Partners's 13F filing for Q3 2020, filed 16 Nov 2020.